Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
90,318,827
-
Total 13F shares
-
52,203,067
-
Share change
-
+51,969,179
-
Total reported value
-
$1,420,860,359
-
Put/Call ratio
-
107%
-
Price per share
-
$27.26
-
Number of holders
-
133
-
Value change
-
+$1,414,485,322
-
Number of buys
-
129
Institutional Holders of Travere Therapeutics, Inc. - COMMON STOCK (TVTX) as of Q4 2020
As of 31 Dec 2020,
Travere Therapeutics, Inc. - COMMON STOCK (TVTX) was held by
133 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,203,067 shares.
The largest 10 holders included
BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., JANUS HENDERSON GROUP PLC, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., MACQUARIE GROUP LTD, BANK OF AMERICA CORP /DE/, MANUFACTURERS LIFE INSURANCE COMPANY, THE, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
134
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.